Primary study · included by 1 review

Topical 5-fluorouracil application in management of odontogenic keratocysts.

Lone 2020 · Akhter Lone Parveen, Ahmed Wani Nisar, Ahmed Janbaz Zubair, et al. · Journal of oral biology and craniofacial research · 2020

Included by

Outcome this study informsPooled effectEvidenceCertainty
Recurrence
5-FU (5% topical) after enucleation and peripheral ostectomy vs Modified Carnoy's solution (MCS) after enucleation and peripheral ostectomy · Follow-up 12 to 108 months across studies
RD -0.199 [-0.283, -0.114]5 studies · 181 participantsModerate
Postoperative paresthesia (any)
5-FU (5% topical) after enucleation and peripheral ostectomy vs Modified Carnoy's solution (MCS) after enucleation and peripheral ostectomy · Follow-up 12 to 108 months across studies
RD -0.158 [-0.281, -0.035]5 studies · 181 participantsModerate
Permanent paresthesia
5-FU (5% topical) after enucleation and peripheral ostectomy vs Modified Carnoy's solution (MCS) after enucleation and peripheral ostectomy · Follow-up 12 to 108 months across studies
RD -0.061 [-0.14, 0.018]5 studies · 181 participantsGRADE not reported

1 including review in total.